Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 390890, 10 pages
Research Article

Natural Antioxidant-Isoliquiritigenin Ameliorates Contractile Dysfunction of Hypoxic Cardiomyocytes via AMPK Signaling Pathway

1Institute of Physiology, School of Basic Medicine Sciences, Lanzhou University, Lanzhou 730000, China
2Department of Pharmacology and Toxicology, School of Medicine and Biomedical Sciences, University at Buffalo-SUNY University of New York, Buffalo, NY 14214, USA
3Department of Cardiovascular Surgery, Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China
4Department of Emergency, Gansu Provincial Hospital, Lanzhou 730000, China
5Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA

Received 16 July 2013; Accepted 14 August 2013

Academic Editor: Fatih Arslan

Copyright © 2013 Xiaoyu Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [17 citations]

The following is the list of published articles that have cited the current article.

  • Yimin Niu, Feng Li, Chikako Inada, Ken Tanaka, Shiro Watanabe, Hironori Fujiwara, Sachie Sasaki-Hamada, Jun-Ichiro Oka, and Kinzo Matsumoto, “Chemical profiling with HPLC-FTMS of exogenous and endogenous chemicals susceptible to the administration of chotosan in an animal model of type 2 diabetes-induced dementia,” Journal of Pharmaceutical and Biomedical Analysis, 2014. View at Publisher · View at Google Scholar
  • Lei Ye, Jianwei Gong, Yonghua Wang, and Xiling Sun, “Pharmacological Activities of Sijunzi Decoction Which Are Related to Its Antioxidant Properties,” Journal of Chemistry, vol. 2014, pp. 1–10, 2014. View at Publisher · View at Google Scholar
  • Lu Gan, Cheng-Jun Ma, Xi-Ling Sun, Ya-Juan Li, Zhen-Hua Wang, Zhan-Yang Wang, Li-Hong Qiu, Ying-Ying Si, Hong Zhang, and Ji Li, “Effect of Isoliquiritigenin on C6 glioma cell proliferation and differentiation,” Chinese Pharmacological Bulletin, vol. 31, no. 9, pp. 1298–1303, 2015. View at Publisher · View at Google Scholar
  • Lara Testai, “Flavonoids and mitochondrial pharmacology: A new paradigm for cardioprotection,” Life Sciences, 2015. View at Publisher · View at Google Scholar
  • Fu Peng, Qiaohui Du, Cheng Peng, Neng Wang, Hailin Tang, Xiaoming Xie, Jiangang Shen, and Jianping Chen, “A Review: The Pharmacology of Isoliquiritigenin,” Phytotherapy Research, 2015. View at Publisher · View at Google Scholar
  • Pille Link, Bernhard Wetterauer, Yujie Fu, and Michael Wink, “Extracts of Glycyrrhiza uralensis and Isoliquiritigenin Counteract Amyloid-beta Toxicity in Caenorhabditis elegans,” Planta Medica, vol. 81, no. 5, pp. 357–362, 2015. View at Publisher · View at Google Scholar
  • Yaya Fan, Shuli Man, Hongfa Li, Yuanxue Liu, Zhen Liu, and Wenyuan Gao, “Analysis of bioactive components and pharmacokinetic study of herb–herb interactions in the traditional Chinese patent medicine Tongmai Yangxin Pill,” Journal of Pharmaceutical and Biomedical Analysis, 2015. View at Publisher · View at Google Scholar
  • Sun-Ji Park, Young-Geun Choe, Jung-Hak Kim, Kyu-Tae Chang, Hyun-Shik Lee, and Dong-Seok Lee, “Isoliquiritigenin impairs insulin signaling and adipocyte differentiation through the inhibition of protein-tyrosine phosphatase 1B oxidation in 3T3-L1 preadipocytes,” Food and Chemical Toxicology, vol. 93, pp. 5–12, 2016. View at Publisher · View at Google Scholar
  • Rosanna Mattera, Monica Benvenuto, Maria Giganti, Ilaria Tresoldi, Francesca Pluchinotta, Sonia Bergante, Guido Tettamanti, Laura Masuelli, Vittorio Manzari, Andrea Modesti, and Roberto Bei, “Effects of Polyphenols on Oxidative Stress-Mediated Injury in Cardiomyocytes,” Nutrients, vol. 9, no. 6, pp. 523, 2017. View at Publisher · View at Google Scholar
  • Cuilan Hou, Wenguang Li, Zengyou Li, Jing Gao, Zhenjie Chen, Xiqiong Zhao, Yaya Yang, Xiaoyu Zhang, and Yong Song, “Synthetic Isoliquiritigenin Inhibits Human Tongue Squamous Carcinoma Cells through Its Antioxidant Mechanism,” Oxidative Medicine and Cellular Longevity, vol. 2017, pp. 1–11, 2017. View at Publisher · View at Google Scholar
  • Dong Gil Lee, Ju-Sik Min, Hyun-Shik Lee, and Dong-Seok Lee, “Isoliquiritigenin attenuates glutamate-induced mitochondrial fission via calcineurin-mediated Drp1 dephosphorylation in HT22 hippocampal neuron cells,” NeuroToxicology, 2018. View at Publisher · View at Google Scholar
  • Yameng Cui, Caihong Li, Chao Zeng, Jiao Li, Zhenyu Zhu, Wanli Chen, Anan Huang, and Xin Qi, “Tongmai Yangxin pills anti-oxidative stress alleviates cisplatin-induced cardiotoxicity: Network pharmacology analysis and experimental evidence,” Biomedicine & Pharmacotherapy, vol. 108, pp. 1081–1089, 2018. View at Publisher · View at Google Scholar
  • Stephane M. Escobar, Genevieve M. Fong, Sheila M.B. Winnischofer, Martin Simone, Lenka Munoz, Joanne M. Dennis, Maria Eliane M. Rocha, and Paul K. Witting, “Anti-proliferative and cytotoxic activities of the flavonoid isoliquiritigenin in the human neuroblastoma cell line SH-SY5Y,” Chemico-Biological Interactions, 2018. View at Publisher · View at Google Scholar
  • Hao Jin, Geom Seog Seo, and Sung Hee Lee, “Isoliquiritigenin-mediated p62/SQSTM1 induction regulates apoptotic potential through attenuation of caspase-8 activation in colorectal cancer cells,” European Journal of Pharmacology, 2018. View at Publisher · View at Google Scholar
  • Onyou Hwang, Ji Ae Lee, Hye Ri Kim, Jiyoung Kim, Ki Duk Park, and Dong Jin Kim, “The novel neuroprotective compound KMS99220 has an early anti-neuroinflammatory effect via AMPK and HO-1, independent of Nrf2,” Experimental Neurobiology, vol. 27, no. 5, pp. 408–418, 2018. View at Publisher · View at Google Scholar
  • Po-Han Lin, Hsiang-Lin Kung, Hsin-Yuan Chen, Ko-Chieh Huang, and Shih-Min Hsia, “Isoliquiritigenin Suppresses E2-Induced Uterine Leiomyoma Growth through the Modulation of Cell Death Program and the Repression of ECM Accumulation,” Cancers, vol. 11, no. 8, pp. 1131, 2019. View at Publisher · View at Google Scholar
  • Haifeng Jin, Yang Jiang, Fengxia Du, Linna Guo, Guan Wang, Sang Chan Kim, Chul Won Lee, Lei Shen, and Rongjie Zhao, “Isoliquiritigenin Attenuates Monocrotaline-Induced Pulmonary Hypertension via Inhibition of the Inflammatory Response and PASMCs Proliferation,” Evidence-Based Complementary and Alternative Medicine, vol. 2019, pp. 1–10, 2019. View at Publisher · View at Google Scholar